Kakali Sarkar

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Hispidulin and Nepetin as Promising Phytochemical Inhibitors of HPV E6: Insights from In Silico Analysis
  In Silico Research in Biomedicine 2026 DOI: 10.1016/j.insi.2026.100546
  +Save
• Epigenetic Therapeutic Potential of Dulcitol, a Sugar Alcohol, as a Multi-Target HDAC Inhibitor against cervical cancer: Insights from In Silico Investigations
  Journal of Contemporary Studies in Science and Innovation 2025 DOI: 10.5281/ZENODO.18230300
  +Save
• Unfolding the role of HDAC2 in the epigenetic puzzle of cancer: A dive into molecular pathways for precision-driven multi-target therapy
  Biochemical Pharmacology 2025 DOI: 10.1016/j.bcp.2025.117534
  +Save
• Repurposing of DrugBank molecules as dual non-hydroxamate HDAC8 and HDAC2 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics studies
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2024.2428829
  +Save
• Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review
  Medical Oncology 2024 DOI: 10.1007/s12032-024-02553-9
  +Save
• In silico identification of dual HDAC8 and MMP9 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics simulation studies for development of antitumour agent
  Interactions 2024 DOI: 10.1007/s10751-024-02083-w
  +Save
• Crucial Structural Understanding for Selective HDAC8 Inhibition: Common Pharmacophores, Molecular Docking, Molecular Dynamics, and Zinc Binder Analysis of selective HDAC8 inhibitors
  Medicinal Chemistry 2024 DOI: 10.2174/0115734064320232240709105228
  +Save